Evidence map›Paper›PMID 39639292›Full record

ArticleMicrobial cell factories2024

Tailored culture strategies to promote antimicrobial secondary metabolite production in Diaporthe caliensis: a metabolomic approach.

Laura V Hoyos, Luis E Vasquez-Muñoz, Yuliana Osorio, Daniela Valencia-Revelo, Daiana Devia-Cometa, Miriam Große, Esteban Charria-Girón, Nelson H Caicedo-Ortega

Abstract read
In one paragraph

Article in Microbial cell factories, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Laura V HoyosDepartamento de Ciencias Biológicas, Bioprocesos y Biotecnología. Facultad de Ingeniería, Diseño y Ciencias Aplicadas, Universidad Icesi, Cali, Colombia.
Luis E Vasquez-MuñozDepartamento de Ciencias Biológicas, Bioprocesos y Biotecnología. Facultad de Ingeniería, Diseño y Ciencias Aplicadas, Universidad Icesi, Cali, Colombia.
Yuliana OsorioDepartamento de Ciencias Biológicas, Bioprocesos y Biotecnología. Facultad de Ingeniería, Diseño y Ciencias Aplicadas, Universidad Icesi, Cali, Colombia.
Daniela Valencia-ReveloDepartamento de Ciencias Biológicas, Bioprocesos y Biotecnología. Facultad de Ingeniería, Diseño y Ciencias Aplicadas, Universidad Icesi, Cali, Colombia.
Daiana Devia-CometaDepartamento de Ciencias Biológicas, Bioprocesos y Biotecnología. Facultad de Ingeniería, Diseño y Ciencias Aplicadas, Universidad Icesi, Cali, Colombia.
Miriam GroßeDepartment Microbial Drugs, Helmholtz Centre for Infection Research (HZI), German Centre for Infection Research (DZIF), Partner Site Hannover-Braunschweig, Inhoffenstrasse 7, 38124, Braunschweig, Germany.
Esteban Charria-GirónDepartment Microbial Drugs, Helmholtz Centre for Infection Research (HZI), German Centre for Infection Research (DZIF), Partner Site Hannover-Braunschweig, Inhoffenstrasse 7, 38124, Braunschweig, Germany. esteban.charriagiron@helmholtz-hzi.de.
Nelson H Caicedo-OrtegaDepartamento de Ciencias Biológicas, Bioprocesos y Biotecnología. Facultad de Ingeniería, Diseño y Ciencias Aplicadas, Universidad Icesi, Cali, Colombia. nhcaicedo@icesi.edu.co.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn the search for new antimicrobial secondary metabolites of fungi, optimizing culture conditions remains a critical challenge, as standard laboratory approaches often result in low yields. While non-selective methods, such as modifying culture media, have been effective in expanding the chemical diversity of fungal metabolites, they have not yet established a direct link to key process parameters crucial for further optimization. This study investigates the capacity of Diaporthe caliensis as a biofactory for biologically active secondary metabolites, employing tailored culture media to explore the relationship between chemical diversity and critical process variables.

resultsThe metabolomic profiles, antibacterial activities, and production yields of the extracts were analyzed to progressively adjust the culture conditions. This study was conducted in five steps, evaluating carbon and nitrogen source concentration, nitrogen source type, salt supplementation, and pH adjustment. Altering the rice starch concentration affected biomass yield per unit of oxygen consumed, while modifications to the nitrogen source concentration influenced both the bioactivity and chemical space by Diaporthe caliensis. Despite changes at the metabolome level, the extracts consistently exhibited potent antibacterial activities, influenced by the nitrogen source, added salts and pH adjustments. For instance, when using corn steep liquor and rice starch, supplemented with micronutrients, different metabolites were produced depending on whether buffer or water was used, though both conditions showed similar antibacterial activities (IC

conclusionsThis study proposes a strategic methodology for the tailored formulation of culture media aiming to promote the biosynthesis of diverse secondary metabolites. This approach revealed the critical role of nutrient limitation and pH regulation in stimulating the production of polyketide-lactone derivatives, including the antibiotic phomol. Ultimately, the systematic, custom-designed culture conditions developed in this work offer a promising strategy for expanding the chemical diversity of Diaporthe caliensis, while providing valuable insights into the key parameters needed for optimizing this fungal biofactory.

Indexed as

AscomycotaCulture MediaMetabolomicsAnti-Bacterial AgentsAnti-Infective AgentsCarbonMetabolomeMicrobial Sensitivity TestsNitrogenSecondary MetabolismAnti-Bacterial AgentsAnti-Infective AgentsCarbonCulture MediaNitrogenAntibacterial activityBiofactoryMetabolomicsNatural productsNutrient limitationPolyketidesSubmerged fermentation

Identifiers

PMID39639292
PMCPMC11619134

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.